isomethyleugenol has been researched along with Brill-Symmers Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyault, S; Carrère, M; Casasnovas, O; Fabiani, B; Haioun, C; Hayette, S; Huet, S; Jardin, F; Lazarovici, J; Mareschal, S; Mescam-Mancini, L; Salles, G; Sohier, E; Taix, S; Tesson, B; Tonon, L; Viari, A; Xerri, L | 1 |
Bozzoli, V; Cupelli, E; D'Alò, F; Giachelia, M; Guidi, F; Hohaus, S; Larocca, LM; Leone, G; Maiolo, E; Martini, M; Massini, G; Tisi, MC; Voso, MT | 1 |
Hirota, S; Imai, Y; Matsuda, I | 1 |
Licht, JD; Martinez-Garcia, E | 1 |
Brandt, M; Creasy, CL; Della Pietra, A; Dhanak, D; Diaz, E; Duquenne, C; Ganji, G; Graves, AP; Korenchuk, S; Kruger, RG; LaFrance, LV; Liu, Y; McCabe, MT; McHugh, CF; Mellinger, M; Miller, WH; Ott, HM; Thompson, C; Tian, X; Tummino, PJ; Van Aller, GS; Verma, SK | 1 |
Chim, CS; Loong, F; Srivastava, G; Wong, KY | 1 |
6 other study(ies) available for isomethyleugenol and Brill-Symmers Disease
Article | Year |
---|---|
EZH2 alterations in follicular lymphoma: biological and clinical correlations.
Topics: Adult; Aged; Cell Line, Tumor; Disease-Free Survival; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Lymphoma, Follicular; Male; Methylation; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Sequence Analysis, RNA | 2017 |
Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Death-Associated Protein Kinases; DNA Methylation; Female; Humans; Lymphoma, Follicular; Male; Methylation; Middle Aged; Prognosis; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction | 2014 |
Global histone modification profiles are well conserved between normal B lymphocytes and neoplastic counterparts.
Topics: Acetylation; Adult; Aged; B-Lymphocytes; Female; Germinal Center; Histones; Humans; Immunohistochemistry; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Methylation; Middle Aged; Protein Processing, Post-Translational | 2010 |
Deregulation of H3K27 methylation in cancer.
Topics: DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Germinal Center; Histones; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lysine; Methylation; Mutation; Polycomb Repressive Complex 2; Transcription Factors | 2010 |
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Indoles; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methylation; Mice; Mutation; Neoplasm Transplantation; Polycomb Repressive Complex 2; Pyridones; Repressor Proteins; Transcriptional Activation; Transplantation, Heterologous | 2012 |
Absence of ATM hypermethylation in mantle cell and follicular lymphoma.
Topics: Ataxia Telangiectasia Mutated Proteins; Base Sequence; Cell Cycle Proteins; DNA-Binding Proteins; Humans; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Methylation; Molecular Sequence Data; Mutation; Protein Serine-Threonine Kinases; Sequence Analysis, DNA; Tumor Suppressor Proteins | 2005 |